These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34124076)

  • 1. Antitumor and Radiosensitization Effects of a CXCR2 Inhibitor in Nasopharyngeal Carcinoma.
    Liu X; Lan T; Mo F; Yang J; Wei Y; Wei X
    Front Cell Dev Biol; 2021; 9():689613. PubMed ID: 34124076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres.
    Lo MC; Yip TC; Ngan KC; Cheng WW; Law CK; Chan PS; Chan KC; Wong CK; Wong RN; Lo KW; Ng WT; Lee WM; Tsao SW; Kwong LW; Lung ML; Mak NK
    Cancer Lett; 2013 Jul; 335(1):81-92. PubMed ID: 23403077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockage of CXCR2 suppresses tumor growth of intrahepatic cholangiocellular carcinoma.
    Sueoka H; Hirano T; Uda Y; Iimuro Y; Yamanaka J; Fujimoto J
    Surgery; 2014 Apr; 155(4):640-9. PubMed ID: 24582495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CXCLs-CXCR2 axis modulates the cross-communication between tumor-associated neutrophils and tumor cells in cervical cancer.
    Ji HZ; Liu B; Ren M; Li S; Zheng JF; Liu TY; Yu HH; Sun Y
    Expert Rev Clin Immunol; 2024 May; 20(5):559-569. PubMed ID: 38224014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CXCR2/CXCL2 signalling pathway - An alternative therapeutic approach in high-grade glioma.
    Acker G; Zollfrank J; Jelgersma C; Nieminen-Kelhä M; Kremenetskaia I; Mueller S; Ghori A; Vajkoczy P; Brandenburg S
    Eur J Cancer; 2020 Feb; 126():106-115. PubMed ID: 31927212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling.
    Qiu WZ; Zhang HB; Xia WX; Ke LR; Yang J; Yu YH; Liang H; Huang XJ; Liu GY; Li WZ; Xiang YQ; Kang TB; Guo X; Lv X
    J Exp Clin Cancer Res; 2018 Apr; 37(1):85. PubMed ID: 29665837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR2 antagonist attenuates neutrophil transmigration into brain in a murine model of LPS induced neuroinflammation.
    Wu F; Chen X; Zhai L; Wang H; Sun M; Song C; Wang T; Qian Z
    Biochem Biophys Res Commun; 2020 Aug; 529(3):839-845. PubMed ID: 32616311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy.
    Chang L; Huang J; Wang K; Li J; Yan R; Zhu L; Ye J; Wu X; Zhuang S; Li D; Zhang G
    BMC Cancer; 2016 Mar; 16():190. PubMed ID: 26951044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.
    Di M; Wang M; Miao J; Chen B; Huang H; Lin C; Jian Y; Li Y; Ouyang Y; Chen X; Wang L; Zhao C
    Biomed Pharmacother; 2020 Mar; 123():109748. PubMed ID: 31869663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound-Stimulated Microbubbles Enhance Radiosensitization of Nasopharyngeal Carcinoma.
    Deng H; Cai Y; Feng Q; Wang X; Tian W; Qiu S; Wang Y; Li Z; Wu J
    Cell Physiol Biochem; 2018; 48(4):1530-1542. PubMed ID: 30071515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological inhibition of CXCR2 alleviates neuropathic pain by inactivating microglia in a rat L5 spinal nerve ligation model.
    Zhou W; Zhou Y; Wang M; Qian C; Wang C; Tang J; Cai Z; Dai W; Zhu X
    Am J Transl Res; 2020; 12(7):3803-3812. PubMed ID: 32774736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL8 Promotes Endothelial-to-Mesenchymal Transition of Endothelial Cells and Protects Cells from Erastin-Induced Ferroptosis via CXCR2-Mediated Activation of the NF-κB Signaling Pathway.
    Ji HZ; Chen L; Ren M; Li S; Liu TY; Chen HJ; Yu HH; Sun Y
    Pharmaceuticals (Basel); 2023 Aug; 16(9):. PubMed ID: 37765018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice.
    Bento AF; Leite DF; Claudino RF; Hara DB; Leal PC; Calixto JB
    J Leukoc Biol; 2008 Oct; 84(4):1213-21. PubMed ID: 18653784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis.
    Xu Z; Fang S; Zuo Y; Zhang Y; Cheng R; Wang Q; Yang Z; Cai W; Ma J; Yang X; Gao G
    Cancer Sci; 2011 Oct; 102(10):1789-98. PubMed ID: 21707863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of CXCR2 suppresses proinflammatory activities of neutrophils in ulcerative colitis.
    Zhu F; He H; Fan L; Ma C; Xu Z; Xue Y; Wang Y; Zhang C; Zhou G
    Am J Transl Res; 2020; 12(9):5237-5251. PubMed ID: 33042416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine-related gene expression in the brain following ischemic stroke: no role for CXCR2 in outcome.
    Brait VH; Rivera J; Broughton BR; Lee S; Drummond GR; Sobey CG
    Brain Res; 2011 Feb; 1372():169-79. PubMed ID: 21138735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of CXCL5-CXCR2 axis promotes proliferation and accelerates G1 to S phase transition of papillary thyroid carcinoma cells and activates JNK and p38 pathways.
    Cui D; Zhao Y; Xu J
    Cancer Biol Ther; 2019; 20(5):608-616. PubMed ID: 30404567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of annexin VII enhances nasopharyngeal carcinoma cell radiosensitivity in vivo and in vitro.
    Gui SJ; Ding RL; Wan YP; Zhou L; Chen XJ; Zeng GQ; He CZ
    Cancer Biomark; 2020; 28(2):129-139. PubMed ID: 31958076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of C-X-C chemokine receptor 2 upregulation with poor prognosis and recurrence in human glioma.
    Yang L; Liu Z; Wu R; Yao Q; Gu Z; Liu M
    Onco Targets Ther; 2015; 8():3203-9. PubMed ID: 26586954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists.
    Erin N; Nizam E; Tanrıöver G; Köksoy S
    Breast Cancer Res Treat; 2015 Feb; 150(1):57-69. PubMed ID: 25682075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.